Clinical trial
Eight Week Primaquine Regimen for the Treatment of Vivax Malaria
NCT00158587 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00158587 |
|---|---|
| Title | Eight Week Primaquine Regimen for the Treatment of Vivax Malaria |
| Official title | A Placebo Controlled, Randomised Evaluation of an Eight Week Primaquine Regimen for the Treatment of Vivax Malaria. |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | HealthNet TPO |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria, Vivax Malaria |
| Intervention type | Drug |
| Interventions | primaquine |
| Enrollment | 150 |
| Start date | Apr 1, 2004 |
| Completion | Mar 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 12, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: